DocDollars

Leadiant Biosciences, Inc.

MD · United States · Reporting entity ID 100000011182

Total reported 2019–2025
$7.12M
#593 of 2,960 reporting companies — 0% of all reported industry payments
$255K in general payments across 480 records, plus $6.86M in research funding across 319 records.

How it breaks down

General payments $255,146
Research funding $6,864,511

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Leadiant Biosciences, Inc. reported $7.12M to US doctors and teaching hospitals from 2019 to 2025, ranking #593 of 2,960 reporting companies. 96% of that was research funding and 4% general payments such as consulting, speaking, food and travel. 480 general payment records and 319 research records were filed.

Common questions about Leadiant Biosciences, Inc.

How much has Leadiant Biosciences, Inc. paid US doctors?

Leadiant Biosciences, Inc. reported $7,119,658 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $255,146 in general payments, $6,864,511 in research funding.

How does Leadiant Biosciences, Inc. rank among drug and device companies?

It ranks #593 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Leadiant Biosciences, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.